SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is currently trending as its highly engaged community fervently champions the 'OG meme' narrative, positioning Rage Comics as a foundational 'meme reset' for the crypto market. Enthusiasts demonstrate strong conviction, actively developing an ecosystem with platforms like RageMaker and RageGames, while rallying others to 'Return to the Memes' and 'Rage On' to establish dominance in the sector. The community believes in the power of real cults behind original memes to move the entire market, advocating for consistency and building over fleeting trends.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors actively discuss a substantial direct offering to a new institutional investor, widely seen as a strategic move to de-risk its Phase 3 MASH trial and enhance leverage for potential partnerships or acquisition. This financing, combined with recent strong analyst price targets and FDA Breakthrough Therapy Designation for pemvidutide, has ignited debate within the community. While many anticipate significant upside and a short squeeze, others voice caution regarding the dilution and its immediate market impact.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as strong semiconductor earnings and anticipation for upcoming mega-cap tech results propel the Nasdaq 100 to new all-time highs. Bulls are celebrating the relentless ascent, frequently dismissing persistent warnings of market manipulation and overbought conditions from bears. The community widely notes the market's tendency to consistently 'buy any dip,' challenging traditional short-selling strategies amid this powerful upward momentum.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as it surges to new all-time highs, ahead of the anticipated FOMC decision and a wave of major tech earnings reports. Bulls are celebrating the strong market momentum, while bears express caution, warning of a potential "blow off top" and market manipulation. The community is actively debating the sustainability of this rally amid a weakening dollar and surging precious metals.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is currently trending as a critical beneficiary of the ongoing AI boom, fueled by record orders, strong guidance, and increased capital expenditures from major chipmakers like TSMC. The community is actively discussing its significant parabolic move, with debates around its valuation and potential for a stock split, while many highlight its indispensable technological monopoly in advanced semiconductor manufacturing.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a significant rally to new all-time highs, driven by growing community concerns over a weakening US dollar and increasing national debt, alongside broader geopolitical uncertainties. Investors are actively discussing a rotation into precious metals as a secure hedge, with many predicting substantial further gains while a minority cautiously eye a potential correction after the rapid ascent.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is actively discussed following an accidental email that prematurely revealed impending widespread layoffs, a move prompting debate among investors. Many view these organizational changes and a strategic shift in grocery focus as a push for greater AI-driven efficiency and cost optimization, while others question the impact on employees and overall business priorities. This ongoing streamlining is set against the backdrop of Amazon Web Services (AWS) continuing to secure major cloud contracts.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending strongly following reports that China has approved the import of its H200 AI chips, a move seen by many as solidifying the company's leadership in the global AI hardware market. This development, alongside ongoing community discussions about its attractive valuation and the massive capital expenditure in AI infrastructure, is fueling widespread bullish sentiment and expectations for continued growth.

Logitech International SA is a holding company, which engages in the design of software-enabled hardware solutions. Its portfolio includes gaming, keyboards and combos, pointing devices, video collaboration, webcams, tablet accessories, and headsets. Its cloud based services includes video conferencing platforms, esports or video games, music streaming platforms, content streaming platforms, and and creativity and productivity platforms. It enhances through software, including machine learning and artificial intelligence. The company was founded by Daniel Borel, Pierluigi Zappacosta, and Giacamo Marini on October 2, 1981 and is headquartered in Lausanne, Switzerland.

Logitech International S.A.

Logitech (LOGI) is trending after delivering a robust earnings report that surpassed expectations and led to a raised fiscal year outlook, driven by strong demand across peripherals, gaming, and productivity tools. Community discussion is actively debating whether this signals a sustainable growth trajectory, with many focusing on the company's strategic shift towards business solutions, AI integration, and diversified supply chains, while also considering prevailing macroeconomic uncertainties and mixed analyst sentiment.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending due to a government proposal signaling a lower-than-expected increase in Medicare Advantage payment rates for 2027, alongside the company's cautious forward outlook. This has sparked intense community discussion, with many investors debating whether the sharp decline represents an overreaction and a significant buying opportunity, or if it indicates deeper policy risks for the healthcare sector. The conversation reflects widespread concern over potential political influence on market valuations and the future profitability of health insurers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock

Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the business's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

Insider Selling: Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock

Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the firm's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates

(RTTNews) - PASSAGE BIO, INC. (PASG) announced Loss for third quarter that decreased from the same period last year and beat the Street estimates...

Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet

The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

The mean of analysts' price targets for Passage Bio (PASG) points to a 1415.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.57	--	--	N/A
Q3 '25	-$2.76	-$2.44	11.51%	BEAT
Q2 '25	-$4.04	-$2.96	26.73%	BEAT
Q1 '25	-$0.23	-$5.00	-2073.91%	MISSED
Q4 '24	-$0.22	-$0.20	11.11%	BEAT

PASG
Passage Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PASG News

PASGPassage Bio Inc